This grant opportunity focuses on creating a comprehensive resource that combines pediatric and perinatal COVID-19 registries to understand the impact on mother-infant pairs. The aim is to study the outcomes of neonates and infants exposed to or infected with SARS-CoV-2. Applications are open until July 6, 2021.
Opportunity ID: 333252
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-FD-21-035 |
| Funding Opportunity Title: | Pediatric and Perinatal COVID-19 Registry (U18) Clinical Trials Optional |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Consumer Protection Food and Nutrition Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 1 |
| Assistance Listings: | 93.103 — Food and Drug Administration Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | May 03, 2021 |
| Last Updated Date: | May 03, 2021 |
| Original Closing Date for Applications: | Jul 06, 2021 |
| Current Closing Date for Applications: | Jul 06, 2021 |
| Archive Date: | Aug 05, 2021 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $2,000,000 |
| Award Floor: | $1,000,000 |
Eligibility
| Eligible Applicants: | County governments Small businesses Private institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments Others (see text field entitled “Additional Information on Eligibility” for clarification) Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education State governments Public and State controlled institutions of higher education Independent school districts For profit organizations other than small businesses Special district governments Native American tribal organizations (other than Federally recognized tribal governments) |
| Additional Information on Eligibility: | Eligible OrganizationsHigher Education InstitutionsPublic/State Controlled Institutions of Higher EducationPrivate Institutions of Higher EducationThe following types of Higher Education Institutions are always encouraged to apply for FDA support as Public or Private Institutions of Higher Education:o Hispanic-serving Institutionso Historically Black Colleges and Universities (HBCUs)o Tribally Controlled Colleges and Universities (TCCUs)o Alaska Native and Native Hawaiian Serving Institutionso Asian American Native American Pacific Islander Serving Institutions (AANAPISIs)Nonprofits Other Than Institutions of Higher EducationNonprofits with 501(c)(3) IRS Status (Other than Institutions of Higher Education)Nonprofits without 501(c)(3) IRS Status (Other than Institutions of Higher Education)For-Profit OrganizationsSmall BusinessesFor-Profit Organizations (Other than Small Businesses)GovernmentsState GovernmentsCounty GovernmentsCity or Township GovernmentsSpecial District GovernmentsIndian/Native American Tribal Governments (Federally Recognized)Indian/Native American Tribal Governments (Other than Federally Recognized)U.S. Territory or PossessionOtherIndependent School DistrictsPublic Housing Authorities/Indian Housing AuthoritiesNative American Tribal Organizations (other than Federally recognized tribal governments)Faith-based or Community-based OrganizationsRegional Organizations |
Additional Information
| Agency Name: | Food and Drug Administration |
| Description: |
The goal of this program is to support the development of a compendium-type resource incorporating pediatric and perinatal COVID-19 registries, natural history, and other data to support the linkage of mother-infant pair data in COVID-19 positive mothers and to identify the short and longer-term outcomes in neonates and infants who are perinatally exposed to and/or test positive for SARS CoV-2. |
| Link to Additional Information: | RFA-FD-21-027 – FULL ANNOUNCEMENT |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Shashi Malhotra
Grants Management Specialist Phone 2404027592 Email:shashi.malhotra@fda.hhs.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | Shashi Malhotra Grants Management Specialist Phone 2404027592 Email: shashi.malhotra@fda.hhs.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 93.103 | RFA-FD-21-035 | FORMS F | PKG00266874 | May 03, 2021 | Jul 06, 2021 | View |
Package 1
Mandatory forms
333252 RR_SF424_2_0-2.0.pdf
333252 PHS398_CoverPageSupplement_4_0-4.0.pdf
333252 RR_OtherProjectInfo_1_4-1.4.pdf
333252 PerformanceSite_2_0-2.0.pdf
333252 RR_KeyPersonExpanded_2_0-2.0.pdf
333252 RR_Budget_1_4-1.4.pdf
333252 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
333252 RR_SubawardBudget30_1_4-1.4.pdf
333252 PHS_AssignmentRequestForm_2_0-2.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
